Quipt Home Medical Corp T.QIPT

management said they were sticking to their guidance

[gibbonsj]

Of 200 million year end 2022 correct? Not sure if it was actually 200 million. I'm sure one of you will know.

[LionGate7]

Reiteration of Outlook for Calendar End 2022 (Fiscal Q1 2023) Based on the current operations, market trends and completed and prospective acquisitions, the Company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal Q1 2023) to be $180-$190 million with $38-$43 million in run-rate Adjusted EBITDA.  I would expect news early next week before the

[LionGate7]

I was expecting a medium to large acquisition by year end and Quipt delivered in style with a better than expected transformative acquisition of Great Elm Healthcare. Greg and his team have delivered as promised, with an effective date of December 31, 2022 with the purchase of a company with $60 million in annual revenues. What a great way to start 2023! I'm expecting 2023 to be a big year for

[lscfa]

Market is forward looking. Even if yearend 2022 target is missed by a bit, co. is going to announce a 2023 year end target which will be considerably higher.   

[gibbonsj]

Not like management to overstate expectations. Do you think 2023 will be the year of the transformational acquisition?

[Tropicalsun]

Speaking with the company IR person a few weeks back, he said that Quipt still expects to meet their forecasted revenue run rate of 180 to 190 million by the end of Calender 2022. I believe they sit right now in the neighborhood of 165 million, so without news of an acquisition of pretty good size, how do they meet the target? Is it a big deal if they don't hit the target? I think from a

[Carlito3311]

This post has been removed in accordance with Community Policy

[lscfa]

p.s. Co. might up its ebitda margin for 2023 revenues due to inflation increase to reimbursement rates which drops straight to ebitda and net income.

[lscfa]

"As of July, we had reached approximately $160 million in run-rate revenue and are well on our way to meeting our outlook." organic growth of 2.5% for each of  Sept qtr and Dec qtr => 160 x1.025 x1.025 = $168 million